Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $128.9150 (-3.37%) ($128.9150 - $134.5700) on Tue. Jul. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 61 | Latest Price | $128.9150(-3.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.3% a day on average for past five trading days. | Weekly Trend | LGND advances 2.4% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(55%) IWC(53%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -1.255% in a week (0% probabilities). VIXM(-26%) UUP(-17%) VXX(-16%) IGOV(-6%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | -2.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $133.14(-3.17%) | 10 Day Moving Average | $133.27(-3.27%) | 20 Day Moving Average | $128.82(0.07%) | To recent high | -17% | To recent low | 14.1% | Market Cap | $2.072b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |